Cargando…
From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids Metabolism
Metabolic syndrome (MS) is a prevalent and severe comorbidity observed in schizophrenia (SZ). The exact nature of this association is controversial and very often accredited to the effects of psychotropic medications and disease-induced life-style modifications, such as inactive lifestyle, poor diet...
Autores principales: | Castillo, Rolando I., Rojo, Leonel E., Henriquez-Henriquez, Marcela, Silva, Hernán, Maturana, Alejandro, Villar, María J., Fuentes, Manuel, Gaspar, Pablo A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100552/ https://www.ncbi.nlm.nih.gov/pubmed/27877101 http://dx.doi.org/10.3389/fnins.2016.00488 |
Ejemplares similares
-
Mutations in sphingolipid metabolism genes are associated with ADHD
por: Henriquez-Henriquez, Marcela, et al.
Publicado: (2020) -
Low serum sphingolipids in children with attention deficit-hyperactivity disorder
por: Henríquez-Henríquez, Marcela P., et al.
Publicado: (2015) -
Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders
por: Di Pardo, Alba, et al.
Publicado: (2018) -
Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis
por: Henriques, Alexandre, et al.
Publicado: (2018) -
Deciphering the link between salicylic acid signaling and sphingolipid metabolism
por: Sánchez-Rangel, Diana, et al.
Publicado: (2015)